Regenicin, Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 0.277514 million compared to USD 0.154125 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 15.35K | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-2.59% | 21.25B | |
-5.29% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- RGIN Stock
- News Regenicin, Inc.
- Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022